FIELD: medicine, oncology.
SUBSTANCE: method involves every day administration thiotriazoline on the background of doxorubicin treatment that is administrated once per a week for 4 weeks. Method provides carrying out correction of toxic damage of heart based on the complex anti-ischemic, membrane-stabilizing, antioxidant and immunomodulating effects of thiotriazoline. Invention can be used in correction of doxorubicin cardiomyopathy.
EFFECT: improved correction method.
3 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| 3-(1H-BENZIMIDAZOL-2-YL) -1,2,2-TRIMETHYL CYCLOPENTANCARBONIC ACID WITH CARDIOPROTECTIVE ACTIVITY | 2017 |
|
RU2645356C1 |
| METHOD FOR TREATING CHRONIC LYMPHOLEUKOSIS | 2003 |
|
RU2245146C1 |
| LYSINIUM 3-METHYL-1,2,4-TRIASOLYL-5-THIOACETATE WITH NEUROPROTECTIVE, NOOTROPIC, CARDIOPROTECTIVE, ENDOTHELIOTROPIC, ANTI-ISCHEMIC, ANTIOXIDANT, ANTI-INFLAMMATORY AND ANTIHYPOXIC EFFECT AND LOW TOXICITY | 2007 |
|
RU2370492C2 |
| METHOD FOR PREVENTING ANTHRACYCLINE CARDIOTOXICITY IN PATIENTS WITH BREAST CANCER | 2014 |
|
RU2546399C1 |
| METHOD FOR PREDICTION OF ANTHRACYCLINE-INDUCED CARDIOTOXICITY IN WOMEN WITH BREAST CANCER | 2019 |
|
RU2714683C1 |
| MEDICINAL AGENT POSSESSING PROTECTIVE EFFECT WITH RESPECT TO OXIDATIVE-TOXIC AND CARDIOTOXIC COMPOUNDS MAINLY | 2000 |
|
RU2268727C2 |
| INOSINE AS AN ANTHRACYCLINE TOXICITY CORRECTOR | 2018 |
|
RU2693825C1 |
| ANTI-ARRHYTHMIC MEDICAMENT "TIODARON" | 2004 |
|
RU2292885C2 |
| GARCINOL AND CYCLODEXTRIN COMPLEX AND METHOD OF ITS APPLICATION | 2011 |
|
RU2566065C2 |
| APPLICATION OF L-LYSINE TIAZOTOTATE AS AN ACTIVE BASIS FOR MEDICINES OF HEPATOPROTECTIVE AND DETOXICATIVE ACTION | 2018 |
|
RU2679447C1 |
